Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

9.84
Delayed Data
As of 1:57pm ET
 +0.38 / +4.02%
Today’s Change
7.09
Today|||52-Week Range
11.47
+18.55%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close9.46
Today’s open9.56
Day’s range9.47 - 9.99
Volume388,579
Average volume (3 months)323,405
Market cap$406.1M
Dividend yield--
Data as of 1:57pm ET, 03/05/2015

Growth & Valuation

Earnings growth (last year)-6.62%
Earnings growth (this year)+107.85%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+712.09%
P/E ratioNM
Price/Sales19.98
Price/Book11.30

Competitors

 Today’s
change
Today’s
% change
LBIOLion Biotechnologies...+0.10+1.06%
SCLNSciClone Pharmaceuti...+0.11+1.38%
HRTXHeron Therapeutics I...+0.60+4.28%
ACRXAcelRx Pharmaceutica...-0.08-0.88%
Data as of 2:11pm ET, 03/05/2015

Financials

Next reporting dateMarch 11, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$12.0M
Annual profit (last year)-$92.3M
Net profit margin-767.73%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account